Evidence map›Paper›PMID 34174481›Full record

ReviewMolecular metabolism2021

In celebration of a century with insulin - Update of insulin gene mutations in diabetes.

Julie Støy, Elisa De Franco, Honggang Ye, Soo-Young Park, Graeme I Bell, Andrew T Hattersley

Open access · goldAbstract readHistorical ArticleReview
In one paragraph

Review in Molecular metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Pancreatic β-cell Dysfunction and Diabetes.Juntendo medical journal · 2025
    Review
  11. Article
  12. MODY Only Monogenic? A Narrative Review of theInternational journal of molecular sciences · 2024
    Review
  13. Article
  14. Article
  15. Insulin Resistance: The Increased Risk of Cancers.Current oncology (Toronto, Ont.) · 2024
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Julie StøySteno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark. Electronic address: julistoe@rm.dk.
Elisa De FrancoInstitute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, United Kingdom. Electronic address: E.De-Franco@exeter.ac.uk.
Honggang YeDepartment of Medicine, The University of Chicago, Chicago, IL, USA. Electronic address: hye@uchicago.edu.
Soo-Young ParkDepartment of Medicine, The University of Chicago, Chicago, IL, USA. Electronic address: sooyoung@uchicago.edu.
Graeme I BellDepartment of Medicine, The University of Chicago, Chicago, IL, USA. Electronic address: gb11@uchicago.edu.
Andrew T HattersleyInstitute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, United Kingdom. Electronic address: A.T.Hattersley@exeter.ac.uk.
University of Chicago · USUniversity of Exeter · GBSteno Diabetes Centers · DKUniversity of Illinois Chicago · US

Funding

Pilot and Feasibility ProgramP30DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI Raghavendra G Mirmira · 2013 to 2026
$20.9M
NIDDK NIH HHS P30 DK020595
6 · The paper itself

Abstract

backgroundWhile insulin has been central to the pathophysiology and treatment of patients with diabetes for the last 100 years, it has only been since 2007 that genetic variation in the INS gene has been recognised as a major cause of monogenic diabetes. Both dominant and recessive mutations in the INS gene are now recognised as important causes of neonatal diabetes and offer important insights into both the structure and function of insulin. It is also recognised that in rare cases, mutations in the INS gene can be found in patients with diabetes diagnosed outside the first year of life. SCOPE OF REVIEW: This review examines the genetics and clinical features of monogenic diabetes resulting from INS gene mutations from the first description in 2007 and includes information from 389 patients from 292 families diagnosed in Exeter with INS gene mutations. We discuss the implications for diagnosing and treating this subtype of monogenic diabetes. MAJOR

conclusionsThe dominant mutations in the INS gene typically affect the secondary structure of the insulin protein, usually by disrupting the 3 disulfide bonds in mature insulin. The resulting misfolded protein results in ER stress and beta-cell destruction. In contrast, recessive INS gene mutations typically result in no functional protein being produced due to reduced insulin biosynthesis or loss-of-function mutations in the insulin protein. There are clinical differences between the two genetic aetiologies, between the specific mutations, and within patients with identical mutations.

Indexed as

Age of OnsetChildChild, PreschoolDiabetes MellitusEndoplasmic Reticulum StressHistory, 21st CenturyHumansInfantInfant, NewbornInheritance PatternsInsulinInsulin-Secreting CellsMutationInsulinGeneticsInsulin biosynthesisInsulin geneMonogenic diabetesNeonatal diabetesPathophysiology

Identifiers

PMID34174481
PMCPMC8513141
OpenAlexW3175069962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.